Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

DS45500853

🥰Excellent
Catalog No. T40349Cas No. 2735803-28-6
Alias DS 45500853

DS45500853 is a novel ERRα agonist that does not activate PPARγ and promotes the recruitment of PGC-1α coactivating peptide by directly binding to ERRα. It has potential for the treatment of metabolic disorders such as type 2 diabetes.

DS45500853

DS45500853

🥰Excellent
Catalog No. T40349Alias DS 45500853Cas No. 2735803-28-6
DS45500853 is a novel ERRα agonist that does not activate PPARγ and promotes the recruitment of PGC-1α coactivating peptide by directly binding to ERRα. It has potential for the treatment of metabolic disorders such as type 2 diabetes.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
DS45500853 is a novel ERRα agonist that does not activate PPARγ and promotes the recruitment of PGC-1α coactivating peptide by directly binding to ERRα. It has potential for the treatment of metabolic disorders such as type 2 diabetes.
In vitro
DS45500853 (0.002, 0.006, 0.017, 0.051, 0.015, 0.046, 1.4, 4.2, 12.5 μg/mL, 18 h) was able to inhibit the transcriptional activity of full-length ERRα in MG63 cells with an EC50 value of 5.4 μM. [1]
SynonymsDS 45500853
Chemical Properties
Molecular Weight284.35
FormulaC18H20O3
Cas No.2735803-28-6
SmilesO=C(C1=CC=C(OC2=CC=C(O)C(=C2)C(C)(C)C)C=C1)C
Relative Density.1.107 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 40 mg/mL (140.67 mM), Sonication and heating are recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween-80+45% Saline: 0.5 mg/mL (1.76 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.5168 mL17.5840 mL35.1679 mL175.8396 mL
5 mM0.7034 mL3.5168 mL7.0336 mL35.1679 mL
10 mM0.3517 mL1.7584 mL3.5168 mL17.5840 mL
20 mM0.1758 mL0.8792 mL1.7584 mL8.7920 mL
50 mM0.0703 mL0.3517 mL0.7034 mL3.5168 mL
100 mM0.0352 mL0.1758 mL0.3517 mL1.7584 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DS45500853 | purchase DS45500853 | DS45500853 cost | order DS45500853 | DS45500853 chemical structure | DS45500853 in vitro | DS45500853 formula | DS45500853 molecular weight